Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)

NCT02905188 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

GENETIC: GLYCAR T cells
DRUG: Cytoxan
DRUG: Fludarabine

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]